T2 Biosystems, Inc. (TTOO)
USD 0.35
(2.88%)
USD 0.35
(2.88%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -8.17 Million USD | -857.2% |
| 2022 | 1.16 Million USD | -84.15% |
| 2021 | 7.35 Million USD | 333.49% |
| 2020 | -3.15 Million USD | 62.62% |
| 2019 | -8.42 Million USD | -71.86% |
| 2018 | -4.9 Million USD | 33.39% |
| 2017 | -7.36 Million USD | -163.68% |
| 2016 | -2.79 Million USD | -360.21% |
| 2015 | 1.07 Million USD | 105.46% |
| 2014 | -19.66 Million USD | -34.04% |
| 2013 | -14.67 Million USD | -25.3% |
| 2012 | -11.7 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -2.14 Million USD | -120.95% |
| 2024 Q2 | -741 Thousand USD | 65.39% |
| 2023 Q1 | -1.91 Million USD | -211.78% |
| 2023 Q4 | -969 Thousand USD | 60.5% |
| 2023 Q3 | -2.45 Million USD | 15.56% |
| 2023 Q2 | -2.9 Million USD | -51.54% |
| 2023 FY | -8.82 Million USD | -857.2% |
| 2022 Q2 | 830 Thousand USD | -19.34% |
| 2022 Q4 | 1.71 Million USD | 171.22% |
| 2022 FY | 1.16 Million USD | -84.15% |
| 2022 Q1 | 1.02 Million USD | -36.4% |
| 2022 Q3 | -2.4 Million USD | -390.12% |
| 2021 Q1 | 1.16 Million USD | 273.72% |
| 2021 Q4 | 1.61 Million USD | -40.25% |
| 2021 Q3 | 2.7 Million USD | 45.36% |
| 2021 FY | 7.35 Million USD | 333.49% |
| 2021 Q2 | 1.86 Million USD | 59.78% |
| 2020 FY | -3.15 Million USD | 62.62% |
| 2020 Q1 | -2.12 Million USD | -292.98% |
| 2020 Q2 | 252 Thousand USD | 111.85% |
| 2020 Q3 | -1.58 Million USD | -730.16% |
| 2020 Q4 | 312 Thousand USD | 119.65% |
| 2019 Q3 | -2.26 Million USD | 24.83% |
| 2019 FY | -8.42 Million USD | -71.86% |
| 2019 Q4 | -541 Thousand USD | 76.14% |
| 2019 Q2 | -3.01 Million USD | -15.87% |
| 2019 Q1 | -2.6 Million USD | 32.2% |
| 2018 Q3 | -576 Thousand USD | -221.78% |
| 2018 FY | -4.9 Million USD | 33.39% |
| 2018 Q1 | -962 Thousand USD | 79.29% |
| 2018 Q2 | 473 Thousand USD | 149.17% |
| 2018 Q4 | -3.83 Million USD | -566.49% |
| 2017 FY | -7.36 Million USD | -163.68% |
| 2017 Q1 | -686 Thousand USD | 45.6% |
| 2017 Q2 | -1.03 Million USD | -50.58% |
| 2017 Q3 | -998 Thousand USD | 3.39% |
| 2017 Q4 | -4.64 Million USD | -365.43% |
| 2016 Q1 | 70 Thousand USD | -30.69% |
| 2016 Q4 | -1.26 Million USD | -55.68% |
| 2016 Q3 | -810 Thousand USD | -2.4% |
| 2016 Q2 | -791 Thousand USD | -1230.0% |
| 2016 FY | -2.79 Million USD | -360.21% |
| 2015 Q4 | 101 Thousand USD | -54.09% |
| 2015 Q2 | -6.08 Million USD | -3390.27% |
| 2015 Q1 | 185 Thousand USD | 103.63% |
| 2015 FY | 1.07 Million USD | 105.46% |
| 2015 Q3 | 220 Thousand USD | 103.61% |
| 2014 Q1 | -5.06 Million USD | -19.6% |
| 2014 Q3 | -4.8 Million USD | -2.13% |
| 2014 Q4 | -5.09 Million USD | -6.0% |
| 2014 FY | -19.66 Million USD | -34.04% |
| 2014 Q2 | -4.7 Million USD | 7.15% |
| 2013 Q4 | -4.23 Million USD | -29.63% |
| 2013 FY | -14.67 Million USD | -25.3% |
| 2013 Q1 | -3.56 Million USD | 0.0% |
| 2013 Q2 | -3.6 Million USD | -1.29% |
| 2013 Q3 | -3.26 Million USD | 9.43% |
| 2012 FY | -11.7 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Bionano Genomics, Inc. | 9.56 Million USD | 185.407% |
| Prenetics Global Limited | 8.82 Million USD | 192.527% |
| Star Equity Holdings, Inc. | 11.92 Million USD | 168.506% |
| CareDx, Inc | 178.32 Million USD | 104.582% |
| Exact Sciences Corporation | 1.84 Billion USD | 100.443% |
| Exagen Inc. | 29.45 Million USD | 127.736% |
| Inotiv, Inc. | 165.44 Million USD | 104.938% |
| Guardant Health, Inc. | 336.89 Million USD | 102.425% |
| Biodesix, Inc. | 36.07 Million USD | 122.646% |
| BioNexus Gene Lab Corp. | 1.32 Million USD | 714.518% |
| Precipio, Inc. | 6.01 Million USD | 235.759% |
| iSpecimen Inc. | 5.1 Million USD | 259.948% |
| Natera, Inc. | 492.74 Million USD | 101.658% |
| Aspira Women's Health Inc. | 5.26 Million USD | 255.264% |
| Standard BioTools Inc. | 50.45 Million USD | 116.194% |
| 23andMe Holding Co. | 99.37 Million USD | 108.221% |
| Castle Biosciences, Inc. | 174.8 Million USD | 104.674% |
| Personalis, Inc. | 18.2 Million USD | 144.87% |
| Aclaris Therapeutics, Inc. | 13.16 Million USD | 162.044% |
| Applied DNA Sciences, Inc. | 5.53 Million USD | 247.648% |
| OpGen, Inc. | -90.69 Thousand USD | -8908.314% |
| Myriad Genetics, Inc. | 476.4 Million USD | 101.715% |
| ICON Public Limited Company | 1.81 Billion USD | 100.45% |
| NeoGenomics, Inc. | 244.6 Million USD | 103.34% |
| Star Equity Holdings, Inc. | 11.92 Million USD | 168.506% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | 100.373% |
| RadNet, Inc. | 93 Million USD | 108.785% |
| MDxHealth SA | 43.92 Million USD | 118.598% |
| Psychemedics Corporation | 8.41 Million USD | 197.112% |
| Illumina, Inc. | 2.74 Billion USD | 100.298% |
| Check-Cap Ltd. | -212 Thousand USD | -3753.774% |
| Twist Bioscience Corporation | 133.34 Million USD | 106.127% |
| DarioHealth Corp. | 5.98 Million USD | 236.531% |
| Fulgent Genetics, Inc. | 104.45 Million USD | 107.821% |
| Sera Prognostics, Inc. | 96 Thousand USD | 8610.417% |
| ENDRA Life Sciences Inc. | -275.45 Thousand USD | -2866.045% |
| OPKO Health, Inc. | 318.12 Million USD | 102.568% |
| Medpace Holdings, Inc. | 524.5 Million USD | 101.558% |
| Neogen Corporation | 463.9 Million USD | 101.761% |
| Intelligent Bio Solutions Inc. | 1.42 Million USD | 673.082% |
| Prenetics Global Limited | 8.82 Million USD | 192.527% |
| Mainz Biomed B.V. | 509.65 Thousand USD | 1703.033% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | 1132.067% |
| Trinity Biotech plc | 19.45 Million USD | 142.005% |
| Neuronetics, Inc. | 51.7 Million USD | 115.801% |
| Sotera Health Company | 577.15 Million USD | 101.416% |
| bioAffinity Technologies, Inc. | 791.61 Thousand USD | 1132.067% |